Lungscape: Resected Non–Small-Cell Lung Cancer Outcome by Clinical and Pathological Parameters
- 1 November 2014
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 9 (11) , 1675-1684
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Squamous Cell Carcinoma of the Lung: Molecular Subtypes and Therapeutic OpportunitiesClinical Cancer Research, 2012
- New driver mutations in non-small-cell lung cancerThe Lancet Oncology, 2011
- Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient dataThe Lancet, 2010
- Impact of Postoperative Radiation Therapy on Survival in Patients With Complete Resection and Stage I, II, or IIIA Non–Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: The Adjuvant Navelbine International Trialist Association (ANITA) Randomized TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative GroupJournal of Clinical Oncology, 2008
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007
- Postoperative Radiotherapy for Stage II or III Non–Small-Cell Lung Cancer Using the Surveillance, Epidemiology, and End Results DatabaseJournal of Clinical Oncology, 2006
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988